Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (ADVN AMP01)

NCT00407069 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00407069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (ADVN AMP01)
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
February 28, 2010
Enrollment
286 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis